目录
- Editorial for the Special Issue on COVID-19
- COVID-19 Fight Enlists Digital Technology: Tracking an Elusive Foe
- COVID-19 Fight Enlists Digital Technology: Contact Tracing Apps
- Challenges in the Development of a Vaccine Against COVID-19
- Ethical Reflection on the Emergency Engineering Management of COVID-19 Epidemic Prevention and Control
- Mesenchymal Stem Cells Represent a Potential Therapeutic Option for Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome
- Strategies and Advances in Combating COVID-19 in China
- Natural Host-Environmental Media-Human:A New Potential Pathway of COVID-19 Outbreak
- The Scientific Foundation of Chinese Herbal Medicine against COVID-19
- Buying Time for an Effective Epidemic Response: The Impact of a Public Holiday for Outbreak Control on COVID-19 Epidemic Spread
- Can Masks Be Reused After Hot Water Decontamination During the COVID-19 Pandemic?
- A Deep Learning System to Screen Novel Coronavirus Disease 2019 Pneumonia
- A High-Throughput, Multi-Index Isothermal Amplification Platform for Rapid Detection of 19 Types of Common Respiratory Viruses Including SARS-CoV-2
- Implementation of Clinical Diagnostic Criteria and Universal Symptom Survey Contributed to Lower Magnitude and Faster Resolution of the COVID-19 Epidemic in Wuhan
- Core Outcome Set for Clinical Trials on Coronavirus Disease 2019(COS-COVID)
- Clinical Study of Mesenchymal Stem Cell Treatment for Acute Respiratory Distress Syndrome Induced by Epidemic Influenza A(H7N9)Infection: A Hint for COVID-19 Treatment
- SARS-CoV-2 Entry Factors: ACE2 and TMPRSS2 Are Expressed in Peri-Implantation Embryos and the Maternal-Fetal Interface
- Clinical Characteristics and Outcomes of Type 2 Diabetes Patients Infected with COVID-19: A Retrospective Study
- Clinical Significance of the Correlation between Changes in the Major Intestinal Bacteria Species and COVID-19 Severity
- Efficacy and Safety of Triazavirin Therapy for Coronavirus Disease 2019:A Pilot Randomized Controlled Trial
- Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study☆
- The Efficacy and Safety of Triazavirin for COVID-19: A Trial Protocol